Your browser doesn't support javascript.
loading
Loss of RUNX1 is associated with aggressive lung adenocarcinomas.
Ramsey, Jon; Butnor, Kelly; Peng, Zhihua; Leclair, Tim; van der Velden, Jos; Stein, Gary; Lian, Jane; Kinsey, C Matthew.
Affiliation
  • Ramsey J; Department of Biochemistry, University of Vermont, Burlington, Vermont.
  • Butnor K; Department of Pathology, University of Vermont Medical Center, Burlington, Vermont.
  • Peng Z; Department of Pathology, University of Vermont Medical Center, Burlington, Vermont.
  • Leclair T; Department of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • van der Velden J; Department of Pathology, University of Vermont Medical Center, Burlington, Vermont.
  • Stein G; Department of Biochemistry, University of Vermont, Burlington, Vermont.
  • Lian J; Department of Biochemistry, University of Vermont, Burlington, Vermont.
  • Kinsey CM; Pulmonary and Critical Care, University of Vermont Medical Center, Burlington, Vermont.
J Cell Physiol ; 233(4): 3487-3497, 2018 04.
Article in En | MEDLINE | ID: mdl-28926105
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Adenocarcinoma / Gene Expression Regulation / Aggression / Core Binding Factor Alpha 2 Subunit / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Adenocarcinoma / Gene Expression Regulation / Aggression / Core Binding Factor Alpha 2 Subunit / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2018 Type: Article